Abstract
Porphyrins are promising materials for photodynamic therapy, but their low solubility and aggregation in biological environments are still obstacles to surpass. In order to overcome these limitations, the conjugation of porphyrins with graphene quantum dots (GQDs), here functioning as a vehicle to improve the internalization of porphyrins by cancer cells, was considered. The GQDs were conjugated with an aminoporphyrin via amide linkage using both thionyl chloride (SOCl2) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide coupling methodologies. Based on structural characterization (Fourier transform infrared and X-ray photoelectron spectroscopy), the best porphyrin loading was observed with the SOCl2 procedure. The new hybrids were investigated as phototherapeutic agents in high incidence breast cancer (T-47D cell line) under white light, and a significant photocytotoxic effect was observed at 10 nM. The conjugation of GQDs to the aminoporphyrin promoted an efficient uptake by the T-47D cells when compared with the nonimmobilized porphyrin. These results point out the high potential of the new hybrids to be explored as theragnostic agents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
